血浆代谢物与双相障碍之间的双向因果关联
研究采用双向代谢组全孟德尔随机化分析,评估871种血浆代谢物与双相障碍(BD)的潜在因果关系,并用DrugBank和ChEMBL评估治疗靶点、贝叶斯共定位识别共享基因组位点。结果显示6种代谢物与BD风险降低显著相关、5种与风险升高显著相关,反向MR未发现BD与任何代谢物水平相关。
要点
- 6种代谢物与双相障碍风险降低显著相关,5种与风险升高显著相关。
- 反向孟德尔随机化分析显示双相障碍与任何代谢物水平均无关联。
- 11种代谢物与双相障碍共享染色体11q12共定位区域,涉及FADS1、FADS2、FADS3和SYT7等基因。
核心结论
- 研究支持血浆代谢物在双相障碍易感性中的因果作用,所识别代谢物可能为双相障碍的预防和治疗提供新途径。
研究设计与样本
- 采用双向代谢组全孟德尔随机化分析,评估871种血浆代谢物与双相障碍之间的潜在因果关系。
- 使用DrugBank和ChEMBL评估相关代谢物是否为潜在治疗靶点,并进行贝叶斯共定位分析识别双相障碍与所识别代谢物共享的基因组位点。
主要发现
- 6种代谢物与双相障碍风险降低显著相关,包括花生四烯酸(20:4n6)(OR:0.90,95% CI:0.84-0.95)和鞘磷脂(d18:2/24:1,d18:1/24:2)(OR:0.92,95% CI:0.87-0.96)。
- 5种代谢物与双相障碍风险升高显著相关,包括1-棕榈酰-2-亚油酰-GPE(16:0/18:2)(OR:1.09,95% CI:1.05-1.13)。
- 反向孟德尔随机化分析显示双相障碍与任何代谢物水平均无关联。
- 留一法分析显示染色体11位点内含MYRF、FADS1和FADS2的SNP可能影响部分因果效应。
- 可成药性评估显示10种双相障碍相关代谢物(如鞘磷脂和胞苷)已被药理干预靶向;共定位分析突出显示11种代谢物与双相障碍共享的一个共定位区域(染色体11q12),并指向FADS1、FADS2、FADS3和SYT7等可能参与基因。
关键数值与推荐
- 6种代谢物与双相障碍风险降低显著相关(OR范围0.90-0.92)。
- 5种代谢物与双相障碍风险升高显著相关(如1-棕榈酰-2-亚油酰-GPE(16:0/18:2)OR:1.09,95% CI:1.05-1.13)。
- 反向孟德尔随机化分析未发现双相障碍与任何代谢物水平相关。
- 共定位分析识别染色体11q12区域由11种代谢物与双相障碍共享。
- 可成药性评估显示10种双相障碍相关代谢物已被药理干预靶向。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Altered levels of human plasma metabolites have been implicated in the etiology of bipolar disorder (BD). However, the causality between metabolites and the disease was not well described. We performed a bidirectional metabolome-wide Mendelian randomization (MR) analysis to evaluate the potential causal relationships between 871 plasma metabolites and BD. We used DrugBank and ChEMBL to evaluate whether related metabolites are potential therapeutic targets. Finally, Bayesian colocalization analysis was performed to identify shared genomic loci BD and identified metabolites. Our MR results showed that six metabolites were significantly associated with a reduced risk of BD, including arachidonate (20:4n6) (OR: 0.90, 95% CI: 0.84-0.95) and sphingomyelin (d18:2/24:1, d18:1/24:2) (OR: 0.92, 95% CI: 0.87-0.96), while five metabolites were significantly associated with an increased risk of BD, including 1-palmitoyl-2-linoleoyl-GPE (16:0/18:2) (OR: 1.09, 95% CI: 1.05-1.13). However, our reverse MR analysis showed that BD was not associated with the levels of any metabolite. Additionally, the leave-one-out analysis revealed SNPs within chromosome 11 loci harboring MYRF, FADS1, and FADS2 as ones with the potential to influence partial causal effects. Druggability evaluation showed that 10 of the BD-related metabolites, such as sphingomyelin and cytidine, have been targeted by pharmacologic intervention. Colocalization analysis highlighted one colocalized region (chromosome 11q12) shared by 11 metabolites and BD and pointed to some genes as possible players, including FADS1, FADS2, FADS3, and SYT7. Our study supported a causal role of plasma metabolites in the susceptibility to BD, and the identified metabolites may provide a new avenue for the prevention and treatment of BD.
引用
- Zhao Q, Baranova A, Liu D, et al. Bidirectional causal associations between plasma metabolites and bipolar disorder. Mol Psychiatry. 2025. PMID: 40169804. doi:10.1038/s41380-025-02977-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。